Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Feb;112(2):166-70.
doi: 10.1007/s00347-014-3091-3.

[Conjunctival amyloidosis]

[Article in German]
Affiliations
Case Reports

[Conjunctival amyloidosis]

[Article in German]
Katerina Hufendiek et al. Ophthalmologe. 2015 Feb.

Abstract

Background: This article reports a case of primary localized conjunctival λ light-chain (AL) amyloidosis.

Methods: Case report.

Results: A 73-year-old woman presented with a 1-year history of a painless growth in the conjunctiva of the left eye. A yellow-salmon pink diffuse mass of tissue was identified in the inferomedial bulbar conjunctiva and inferior fornix. An incisional biopsy was performed. The histopathological and immunohistochemical examinations revealed interstitial and vascular amyloid deposits of λ light chains. The diagnosis was amyloidosis of the conjunctiva. The systemic evaluation revealed normal findings and systemic amyloidosis was excluded. Nevertheless, due to an unexplained cardiac insufficiency and after consultation with the treating hematologist a treatment with three cycles of systemic chemotherapy with melphalan and prednisolone was initiated but 6 months later the conjunctival mass in the inferior fornix showed persistence and complete excision was performed. At 16, 24 and 44 months of follow-up no evidence of recurrence was seen on clinical examination. The magnetic resonance imaging (MRI) at 16 and 24 months of follow-up showed no associated cranial or orbital infiltration.

Conclusion: Conjunctival AL amyloidosis is a rare clinical entity. Because of the heterogeneity of amyloidosis in clinical presentation, pattern of amyloid-related organ toxicity, association with lymphoproliferative diseases and rate of disease progression, identification of amyloid deposits is essential and systemic involvement has to be excluded.

PubMed Disclaimer

References

    1. Amyloid. 2005 Mar;12(1):1-4 - PubMed
    1. Surv Ophthalmol. 2006 Jul-Aug;51(4):419-33 - PubMed
    1. Arch Ophthalmol. 2009 May;127(5):645-8 - PubMed
    1. Surv Ophthalmol. 1995 Nov-Dec;40(3):173-96 - PubMed

LinkOut - more resources